Optowire
Payments companies reported to CMS as associated with Optowire. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Optowire, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Optowire
These are the largest totals companies reported as associated with Optowire. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ramin Hastings | Hasbrouck Heights, NJ | Interventional Cardiology | $24,298.72 |
| Nouri Al Khaled | Evergreen Park, IL | Cardiovascular Disease | $11,250.00 |
| Ronald Caputo | Naples, FL | Cardiovascular Disease | $9,020.32 |
| Ruby Satpathy | Jacksonville, FL | Interventional Cardiology | $5,250.00 |
| Philippe Genereux | New York, NY | Cardiovascular Disease | $5,002.69 |
| Eric Osborn | Boston, MA | Interventional Cardiology | $1,088.94 |
| Dominick Bufalino | Downers Grove, IL | Interventional Cardiology | $822.99 |
| Mahesh Raju | Downers Grove, IL | Interventional Cardiology | $740.36 |
| Pierre Istfan | Bristol, TN | Interventional Cardiology | $711.73 |
| Peter Kerwin | Downers Grove, IL | Interventional Cardiology | $599.69 |
Prescribed Optowire?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.